Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Aug 12, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Trinity Biotech filed its monthly 6-K, nothing new, just standard reporting.
AI Summary
Trinity Biotech plc filed a Form 6-K on August 12, 2025, reporting for the month of August 2025. The company, based in Dublin, Ireland, is a foreign private issuer and will file its annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Trinity Biotech is fulfilling its regular reporting obligations as a foreign private issuer, which is standard for maintaining its public listing.
Risk Assessment
Risk Level: low — This is a routine filing with no new material information, financial data, or significant corporate events disclosed.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0000888721 (company) — Central Index Key
- 2835 (company) — Standard Industrial Classification Code
- August 2025 (date) — Reporting Period
- 20250812 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or the rules of any stock exchange on which it is listed.
What is Trinity Biotech's fiscal year end?
Trinity Biotech's fiscal year ends on December 31 (1231).
Does Trinity Biotech file annual reports under Form 20-F or 40-F?
Trinity Biotech files its annual reports under cover of Form 20-F.
Where is Trinity Biotech's principal executive office located?
Trinity Biotech's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Is this filing providing any new financial results or material updates?
No, this Form 6-K is a routine report for the month of August 2025 and does not appear to contain specific new financial results or material operational updates beyond its status as a foreign private issuer.
Filing Stats: 372 words · 1 min read · ~1 pages · Grade level 11.3 · Accepted 2025-08-12 16:33:33
Filing Documents
- zk2533582.htm (6-K) — 15KB
- exhibit_99-1.htm (EX-99.1) — 16KB
- exhibit_99-2.htm (EX-99.1) — 930KB
- exhibit_99-3.htm (EX-99.3) — 146KB
- image0.jpg (GRAPHIC) — 90KB
- image1.jpg (GRAPHIC) — 50KB
- 0001178913-25-002814.txt ( ) — 1301KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Susan O'Connor Susan O'Connor Interim Chief Financial Officer Date: August 12, 2025